FHIR IG analytics
| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | ValueSet-2.16.840.1.113883.3.1444.3.101.json |
| FHIR Version | R4 |
| Source | https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.3.101/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.101 |
| Version | 20230707 |
| Status | active |
| Date | 2023-07-07T01:01:08-04:00 |
| Name | TrastuzumabAndBiosimilars |
| Title | Trastuzumab and Biosimilars |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: This value set contains concepts that represent the medication Trastuzumab and Trastuzumab biosimilars.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; injectable Trastuzumab and Trastuzumab biosimilars.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.) |
Resources that use this resource
Resources that this resource uses
Narrative
No narrative content found in resource
Source1
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113883.3.1444.3.101",
"meta": {
"versionId": "14",
"lastUpdated": "2023-12-21T17:43:03.000-05:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "American Society of Clinical Oncology Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2024-12-05"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2023-07-07"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.101",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113883.3.1444.3.101"
}
],
"version": "20230707",
"name": "TrastuzumabAndBiosimilars",
"title": "Trastuzumab and Biosimilars",
"status": "active",
"date": "2023-07-07T01:01:08-04:00",
"publisher": "American Society of Clinical Oncology Steward",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: This value set contains concepts that represent the medication Trastuzumab and Trastuzumab biosimilars.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; injectable Trastuzumab and Trastuzumab biosimilars.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.)",
"compose": {
"include": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept": [
{
"code": "1658084",
"display": "ado-trastuzumab emtansine 100 MG Injection"
},
{
"code": "1658089",
"display": "ado-trastuzumab emtansine 160 MG Injection"
},
{
"code": "1922509",
"display": "trastuzumab 150 MG Injection"
},
{
"code": "1922516",
"display": "trastuzumab 21 MG/ML Injectable Solution"
},
{
"code": "2107053",
"display": "trastuzumab-pkrb 21 MG/ML Injectable Solution"
},
{
"code": "2119714",
"display": "5 ML hyaluronidase-oysk 2000 UNT/ML / trastuzumab-oysk 120 MG/ML Injection"
},
{
"code": "2169359",
"display": "trastuzumab-pkrb 150 MG Injection"
},
{
"code": "2174804",
"display": "trastuzumab-anns 21 MG/ML Injectable Solution"
},
{
"code": "2179753",
"display": "trastuzumab-dkst 150 MG Injection"
},
{
"code": "2179760",
"display": "trastuzumab-dkst 21 MG/ML Injectable Solution"
},
{
"code": "2257297",
"display": "trastuzumab-anns 150 MG Injection"
},
{
"code": "2267576",
"display": "fam-trastuzumab deruxtecan-nxki 100 MG Injection"
},
{
"code": "2280732",
"display": "trastuzumab-qyyp 21 MG/ML Injectable Solution"
},
{
"code": "2289227",
"display": "trastuzumab-dttb 150 MG Injection"
},
{
"code": "2289234",
"display": "trastuzumab-dttb 21 MG/ML Injectable Solution"
},
{
"code": "2382604",
"display": "15 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 80 MG/ML / trastuzumab-zzxf 40 MG/ML Injection"
},
{
"code": "2383305",
"display": "10 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 60 MG/ML / trastuzumab-zzxf 60 MG/ML Injection"
},
{
"code": "2472791",
"display": "trastuzumab-qyyp 150 MG Injection"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:ec1dfdee-38eb-44be-b926-fb5b591386ec",
"timestamp": "2025-05-23T21:51:53-04:00",
"total": 17,
"contains": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1658084",
"display": "ado-trastuzumab emtansine 100 MG Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1658089",
"display": "ado-trastuzumab emtansine 160 MG Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1922509",
"display": "trastuzumab 150 MG Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2107053",
"display": "trastuzumab-pkrb 21 MG/ML Injectable Solution"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2119714",
"display": "5 ML hyaluronidase-oysk 2000 UNT/ML / trastuzumab-oysk 120 MG/ML Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2169359",
"display": "trastuzumab-pkrb 150 MG Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2174804",
"display": "trastuzumab-anns 21 MG/ML Injectable Solution"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2179753",
"display": "trastuzumab-dkst 150 MG Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2179760",
"display": "trastuzumab-dkst 21 MG/ML Injectable Solution"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2257297",
"display": "trastuzumab-anns 150 MG Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2267576",
"display": "fam-trastuzumab deruxtecan-nxki 100 MG Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2280732",
"display": "trastuzumab-qyyp 21 MG/ML Injectable Solution"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2289227",
"display": "trastuzumab-dttb 150 MG Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2289234",
"display": "trastuzumab-dttb 21 MG/ML Injectable Solution"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2382604",
"display": "15 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 80 MG/ML / trastuzumab-zzxf 40 MG/ML Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2383305",
"display": "10 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 60 MG/ML / trastuzumab-zzxf 60 MG/ML Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2472791",
"display": "trastuzumab-qyyp 150 MG Injection"
}
]
}
}
FHIR
FHIRsmith